article in BusinessSpectator today
China’s strong demand for Aussie vitamins could see a $1bn trade sale of Nature’s Care, while Ferrovial mulls its next move in its chase for Broadspectrum.
A $1 billion vitamin deal is in the works as the appetite for such China-facing companies refuses to die down despite market turbulence.
Elsewhere, NAB faces judgment day on its UK operations, Ferrovial ponders the next move in its chase of Broadspectrum and Woolworths’ rivals look to benefit from the likely liquidation of Masters.
China’s unwavering demand for Australian vitamins is tipped to lead to a sale of Nature’s Care at a multiple as high as 25 times earnings, The Australian Financial Review reports. The privately-run group tapped JPMorgan and Ord Minnett to run a trade sale over the weekend, with interest to start being drummed up from this week.
The strong valuation could deliver over $1bn in proceeds to the vitamins outfit as there is no intention for its current owners to retain a slice.
The auction follows last year’s sale of Swisse Wellness for $1.6bn and a stunning surge in Blackmores stock above $200.
Add to My Watchlist
What is My Watchlist?
